13F Pro

SEC Form 4 reporting owner

Denyes Nancy

Denyes Nancy has filed 3 Form 4 transactions reported between January 9, 2026 and February 4, 2026, as General Counsel of aTYR PHARMA INC.

Name as filed: DENYES NANCY

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1K
1 lines
Companies
1
with Form 4 filings
Latest transaction
Feb 4, 2026
transaction date

Roles and reported holdings

  • ATYRaTYR PHARMA INC
    Jan 9, 2026 – Feb 4, 2026

    General Counsel

    Held directly33,124 sh as of Feb 4, 2026 · Form 4

    24 months: $1K sold

Transaction history

All 3 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Feb 4, 2026ATYRGeneral CounselOpen-market saleCode S · direct1,118$1K@ $0.9761Form 4
Feb 3, 2026ATYRGeneral CounselOption exerciseCode M · direct2,687—Form 4
Jan 9, 2026ATYRGeneral CounselGrant or awardCode A · direct412,500—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.